Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 50 MG/ML INJ SUSP, For IM, IA Us
Recalled March 11, 2020 · FDA recall D-0972-2020 · Fusion IV Pharmaceuticals, Inc.
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Description
Lack of Assurance of Sterility
Product
Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 50 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0636-1
Manufacturer(s)
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →